It has previously been shown that interleukin-6 is positively correlated with pain intensity in advanced, stable multiple myeloma [37] and several other inflammatory cytokines that have been correlated to pain in patients with cancer-induced bone pain [38,39]. The gene discussed is IL6; the disease is cancer.